Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fredrik Karpe

Showing results (1-10 of 248) with videos related to

Pageof 25
Sort By:
Atherosclerosis. Supplements|June 5, 2002
Postprandial lipemia--effect of lipid-lowering drugsFredrik Karpe
Current Opinion in Lipidology|July 18, 2012
Chylomicron production as a feature of atherogenic lipoproteinsFredrik Karpe
International Journal of Epidemiology|September 2, 2016
Commentary: Chylomicronaemia, fat tolerance and atherosclerosis-a commentary on a landmark paperFredrik Karpe
Diabetes|February 23, 2013
Insulin resistance by adiponectin deficiency: is the action in skeletal muscle?Fredrik Karpe
Current Opinion in Lipidology|May 14, 2010
Hyperlipidaemia and cardiovascular disease: nonantilipolytic effects of nicotinic acid in adipose tissueFredrik Karpe, Liliane Chamas
Lancet (London, England)|December 21, 2002
Fire-and-forget in prevention of coronary heart diseaseFredrik Karpe, Rury Holman
Current Opinion in Clinical Nutrition and Metabolic Care|January 18, 2013
Is there something special about palmitoleate?Leanne Hodson, Fredrik Karpe
Current Opinion in Lipidology|May 24, 2012
Determinants of VLDL-triglycerides productionSøren Nielsen, Fredrik Karpe
Arteriosclerosis, Thrombosis, and Vascular Biology|July 25, 2008
Caution on the interpretation of plasma fatty acid composition as a proxy marker for SCD1 activity: particular implications for using the 16:1/16:0 ratio in QTL studies involving hyperlipidemic patientsFredrik Karpe, Leanne Hodson
Endocrine Connections|October 4, 2019
Hyperinsulinaemia: does it tip the balance toward intrahepatic fat accumulation?Leanne Hodson, Fredrik Karpe
Pageof 25

Showing results (1-10 of 248) with videos related to

Sort By:
Pageof 25
Atherosclerosis. Supplements|June 5, 2002
Postprandial lipemia--effect of lipid-lowering drugsFredrik Karpe
Current Opinion in Lipidology|July 18, 2012
Chylomicron production as a feature of atherogenic lipoproteinsFredrik Karpe
International Journal of Epidemiology|September 2, 2016
Commentary: Chylomicronaemia, fat tolerance and atherosclerosis-a commentary on a landmark paperFredrik Karpe
Diabetes|February 23, 2013
Insulin resistance by adiponectin deficiency: is the action in skeletal muscle?Fredrik Karpe
Current Opinion in Lipidology|May 14, 2010
Hyperlipidaemia and cardiovascular disease: nonantilipolytic effects of nicotinic acid in adipose tissueFredrik Karpe, Liliane Chamas
Lancet (London, England)|December 21, 2002
Fire-and-forget in prevention of coronary heart diseaseFredrik Karpe, Rury Holman
Current Opinion in Clinical Nutrition and Metabolic Care|January 18, 2013
Is there something special about palmitoleate?Leanne Hodson, Fredrik Karpe
Current Opinion in Lipidology|May 24, 2012
Determinants of VLDL-triglycerides productionSøren Nielsen, Fredrik Karpe
Arteriosclerosis, Thrombosis, and Vascular Biology|July 25, 2008
Caution on the interpretation of plasma fatty acid composition as a proxy marker for SCD1 activity: particular implications for using the 16:1/16:0 ratio in QTL studies involving hyperlipidemic patientsFredrik Karpe, Leanne Hodson
Endocrine Connections|October 4, 2019
Hyperinsulinaemia: does it tip the balance toward intrahepatic fat accumulation?Leanne Hodson, Fredrik Karpe
Pageof 25